OSI Closes Lid On Eyetech Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite last-minute blink surrounding potential Macugen competition from Genentech’s Lucentis, OSI announces completion of the $935 mil. merger.